| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | REGENERON PHARMACEUTICALS, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$640,000 | |
| 2025 | REGENERON PHARMACEUTICALS, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$610,000 | |
| 2025 | REGENERON PHARMACEUTICALS, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$570,000 | |
| 2025 | REGENERON PHARMACEUTICALS, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$610,000 | |
| 2025 | REGENERON PHARMACEUTICALS, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$400,000 | |
| 2024 | REGENERON PHARMACEUTICALS, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$400,000 | |
| 2024 | REGENERON PHARMACEUTICALS, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$400,000 | |
| 2024 | REGENERON PHARMACEUTICALS, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$400,000 | |
| 2024 | REGENERON PHARMACEUTICALS, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$430,000 | |
| 2023 | REGENERON PHARMACEUTICALS, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$430,000 |
| Firm | Filings | Expenses |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC | 40 | $13,070,000 |
| Issue | Activities |
|---|---|
| Health Issues | 40 |
| Medicare/Medicaid | 38 |
| Copyright/Patent/Trademark | 30 |
| Taxation/Internal Revenue Code | 15 |
| Trade (domestic/foreign) | 5 |
| Budget/Appropriations | 3 |